August 15, 2025 at 12:11AM FDA Approves First Immunotherapy for Recurrent Respiratory Papillomatosis

FDA approved Papzimeos, the first-of-its-kind non-replicating adenoviral vector-based immunotherapy for use in adults with recurrent respiratory papillomatosis.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/Bb62817